Annual Total Liabilities
$17.96 M
+$10.26 M+133.28%
December 31, 2023
Summary
- As of February 26, 2025, ANVS annual total liabilities is $17.96 million, with the most recent change of +$10.26 million (+133.28%) on December 31, 2023.
- During the last 3 years, ANVS annual total liabilities has risen by +$17.38 million (+3004.96%).
- ANVS annual total liabilities is now at all-time high.
Performance
ANVS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$7.30 M
+$500.60 K+7.36%
September 30, 2024
Summary
- As of February 26, 2025, ANVS quarterly total liabilities is $7.30 million, with the most recent change of +$500.60 thousand (+7.36%) on September 30, 2024.
- Over the past year, ANVS quarterly total liabilities has increased by +$3.73 million (+104.72%).
- ANVS quarterly total liabilities is now -59.36% below its all-time high of $17.96 million, reached on December 31, 2023.
Performance
ANVS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ANVS Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +133.3% | +104.7% |
| 3 y3 years | +3005.0% | +104.7% |
| 5 y5 years | +134.9% | +104.7% |
ANVS Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1092.1% | -59.4% | +480.9% |
| 5 y | 5-year | at high | +3005.0% | -59.4% | +2496.2% |
| alltime | all time | at high | +3005.0% | -59.4% | +2496.2% |
Annovis Bio Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.30 M(+7.4%) |
| Jun 2024 | - | $6.80 M(-39.1%) |
| Mar 2024 | - | $11.17 M(-37.8%) |
| Dec 2023 | $17.96 M(+133.3%) | $17.96 M(+403.8%) |
| Sep 2023 | - | $3.56 M(+71.9%) |
| Jun 2023 | - | $2.07 M(-61.7%) |
| Mar 2023 | - | $5.41 M(-29.7%) |
| Dec 2022 | $7.70 M(+411.0%) | $7.70 M(+204.7%) |
| Sep 2022 | - | $2.53 M(+94.4%) |
| Jun 2022 | - | $1.30 M(+3.4%) |
| Mar 2022 | - | $1.26 M(-16.6%) |
| Dec 2021 | $1.51 M | $1.51 M(+34.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $1.12 M(+26.8%) |
| Jun 2021 | - | $884.10 K(-44.6%) |
| Mar 2021 | - | $1.60 M(+176.1%) |
| Dec 2020 | $578.40 K(-94.0%) | $578.40 K(+105.8%) |
| Sep 2020 | - | $281.10 K(-60.0%) |
| Jun 2020 | - | $702.90 K(-6.2%) |
| Mar 2020 | - | $749.30 K(-92.3%) |
| Dec 2019 | $9.69 M(+26.8%) | $9.69 M(+10.7%) |
| Sep 2019 | - | $8.75 M(+4.0%) |
| Jun 2019 | - | $8.42 M(+2.6%) |
| Mar 2019 | - | $8.21 M(+7.4%) |
| Dec 2018 | $7.64 M(+4.4%) | $7.64 M |
| Dec 2017 | $7.32 M | - |
FAQ
- What is Annovis Bio annual total liabilities?
- What is the all time high annual total liabilities for Annovis Bio?
- What is Annovis Bio annual total liabilities year-on-year change?
- What is Annovis Bio quarterly total liabilities?
- What is the all time high quarterly total liabilities for Annovis Bio?
- What is Annovis Bio quarterly total liabilities year-on-year change?
What is Annovis Bio annual total liabilities?
The current annual total liabilities of ANVS is $17.96 M
What is the all time high annual total liabilities for Annovis Bio?
Annovis Bio all-time high annual total liabilities is $17.96 M
What is Annovis Bio annual total liabilities year-on-year change?
Over the past year, ANVS annual total liabilities has changed by +$10.26 M (+133.28%)
What is Annovis Bio quarterly total liabilities?
The current quarterly total liabilities of ANVS is $7.30 M
What is the all time high quarterly total liabilities for Annovis Bio?
Annovis Bio all-time high quarterly total liabilities is $17.96 M
What is Annovis Bio quarterly total liabilities year-on-year change?
Over the past year, ANVS quarterly total liabilities has changed by +$3.73 M (+104.72%)